Citadel Advisors’s Bio Green Med Solution Inc BGMS Stock Holding History

Citadel Advisors’s Portfolio BGMS Stock Details BGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	-$400	–	14836
2022 Q4	–	Hold	0	–	–	–	14672
2022 Q1	–	Sell	-6	Closed	-$78K	–	13735
2021 Q4	$78K	Sell	6 -2	-25%	-$32.1K	﹤0.01%	12958
2021 Q3	$154K	Buy	+8	New	+$154K	﹤0.01%	12347

Other funds holding BGMS

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

AIC

Archer Investment Corporation Carmel, Indiana $522M AUM 26.29% 1-Year Est. Return

Citadel Advisors's BGMS Position: Q2 2026 in Review

Citadel Advisors increased its Bio Green Med Solution Inc (BGMS) stake by 241% in Q2 2026, buying an estimated $51.3K and bringing the position to 75,240 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12949.

Citadel Advisors first reported a position in BGMS in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.09M in Q1 2021. 7 funds tracked by Wall St. Rank hold BGMS as of Q2 2026.

Citadel Advisors held 75,240 shares of Bio Green Med Solution Inc worth $68.5K as of Q2 2026.
Citadel Advisors bought 53,189 Bio Green Med Solution Inc shares in Q2 2026, an estimated $51.3K.
Bio Green Med Solution Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12949 holding.
Citadel Advisors first reported a position in Bio Green Med Solution Inc in Q4 2017 and has held it in 15 quarters since.
Citadel Advisors's Bio Green Med Solution Inc position peaked at $2.09M in Q1 2021.
7 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.